Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2026)
Camp4 Therapeutics' Interest & Investment Income was $807,000 in Q2 2026, up 78.1% from $453,000 a year earlier but down 11.3% from the prior quarter.
Powered by 
Analysis
Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Camp4 Therapeutics' Interest & Investment Income was $2.85 million through Jun 30, 2026, up 63.3% year-over-year; for FY2025, it came in at $2.17 million, up 63.5% from FY2024.
- In earlier years, Interest & Investment Income was $1.33 million in FY2024 (-52.6%) and $2.81 million in FY2023.
- Quarterly Interest & Investment Income has moved between $94,000 (Q3 2024) and $910,000 (Q1 2026) over five years.
- Compared with a year earlier, Interest & Investment Income has increased for seven straight quarters, with growth averaging 70.6% over the last eight quarters.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2025 (growth of 350.0%); the worst was Q3 2024 (a decline of 86.4%).
- Per Business Quant data, CAMP's Interest & Investment Income in the three quarters before Q2 2026 was $910,000 (Q1 2026), $710,000 (Q4 2025) and $423,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Camp4 Therapeutics | 341.83 Mn | -77.81 Mn | - | 984,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 984,000.00 |
| Jun 30, 2026 | 807,000.00 |
| Mar 31, 2026 | 910,000.00 |
| Dec 31, 2025 | 710,000.00 |
| Sep 30, 2025 | 423,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Mar 31, 2025 | 588,000.00 |
| Dec 31, 2024 | 610,000.00 |
| Sep 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 231,000.00 |
| Mar 31, 2024 | 395,000.00 |
| Dec 31, 2023 | 569,000.00 |
| Sep 30, 2023 | 689,000.00 |
API Access
Camp4 Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CAMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CAMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CAMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();